SARS

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Retrieved on: 
Thursday, March 28, 2024

Our drug-discovery process focuses on the highly conserved regions of the viral enzymes and inhibitor-enzyme interactions at the atomic level.

Key Points: 
  • Our drug-discovery process focuses on the highly conserved regions of the viral enzymes and inhibitor-enzyme interactions at the atomic level.
  • Cocrystal reported unrestricted cash as of December 31, 2023 of $26.4 million, compared with $37.1 million as of December 31, 2022.
  • Net cash used in operating activities for 2023 was $14.7 million, compared with $21.4 million for 2022.
  • The Company had working capital of $25.0 million and 10.2 million common shares outstanding as of December 31, 2023.

University Hospital of Southampton NHS Foundation Trust

Retrieved on: 
Tuesday, April 9, 2024

A reprimand is being issued to University Hospital of Southampton NHS Foundation Trust as they have only responded to 59% of incoming SARs within the statutory timeframe during the period of 01 August 2022 to 01 July 2023.

Key Points: 

A reprimand is being issued to University Hospital of Southampton NHS Foundation Trust as they have only responded to 59% of incoming SARs within the statutory timeframe during the period of 01 August 2022 to 01 July 2023.
University Hospital of Southampton NHS Foundation Trust

Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled Antibody Platform Over Systemic Dosing

Retrieved on: 
Wednesday, March 20, 2024

The study upends prevailing thinking about inhaled antibody delivery by demonstrating that antibodies maintain their activity following nebulization and can be dosed uniformly to all parts of the respiratory tract, including the deep lung.

Key Points: 
  • The study upends prevailing thinking about inhaled antibody delivery by demonstrating that antibodies maintain their activity following nebulization and can be dosed uniformly to all parts of the respiratory tract, including the deep lung.
  • It also shows that inhaled antibodies can achieve concentrations throughout the respiratory tract greatly exceeding the levels required to neutralize most acute respiratory viruses.
  • The greater convenience, dose savings and reduced burden on healthcare infrastructure supports initiating inhaled antibody treatment at the earliest time possible.
  • The much greater antibody concentrations achieved in the respiratory tract with inhalation suggests the potential for even greater therapeutic effect.

Indira Lakshmanan Joins U.S. News as Ideas & Opinions Editor

Retrieved on: 
Wednesday, April 3, 2024

WASHINGTON, April 3, 2024 /PRNewswire/ -- U.S. News & World Report, the global authority in empowering informed decisions through news, rankings and advice, today announced that Indira Lakshmanan has joined the company to start an Ideas & Opinions platform. In this newly created role, Lakshmanan will be responsible for developing and overseeing content that provides perspective, insight and thought leadership around current issues and events.

Key Points: 
  • WASHINGTON, April 3, 2024 /PRNewswire/ -- U.S. News & World Report, the global authority in empowering informed decisions through news, rankings and advice, today announced that Indira Lakshmanan has joined the company to start an Ideas & Opinions platform.
  • In this newly created role, Lakshmanan will be responsible for developing and overseeing content that provides perspective, insight and thought leadership around current issues and events.
  • U.S. News is the right platform to share insightful ideas and opinions, and Indira is the perfect person to lead this effort."
  • I'm excited to expand that platform to feature thought leaders who will bring fresh ideas and perspectives to local, national and global conversations."

Gilbarco Veeder-Root champions fuel efficiency, clean fuels and diesel rebate solutions in mining

Retrieved on: 
Thursday, March 28, 2024

As part of a holistic approach to mining excellence, Kapito explains that Gilbarco's integrated fuel and fleet management technology solutions are designed to address the multifaceted challenges of the mining industry.

Key Points: 
  • As part of a holistic approach to mining excellence, Kapito explains that Gilbarco's integrated fuel and fleet management technology solutions are designed to address the multifaceted challenges of the mining industry.
  • In addition, the introduction of Gilbarco's clean fuel solution exemplifies the company's commitment to maintaining equipment integrity and performance.
  • Gilbarco's comprehensive site automation solutions empower mining companies with critical data analytic insights, facilitating efficient monitoring and management of fleet and fuel inventory.
  • Integral to the company's solutions is compliance with Global Industry Standards and environmental stewardship, from leak detection to vapour recovery and clean fuel technologies.

Gilbarco Veeder-Root champions fuel efficiency, clean fuels and diesel rebate solutions in mining

Retrieved on: 
Thursday, March 28, 2024

As part of a holistic approach to mining excellence, Kapito explains that Gilbarco's integrated fuel and fleet management technology solutions are designed to address the multifaceted challenges of the mining industry.

Key Points: 
  • As part of a holistic approach to mining excellence, Kapito explains that Gilbarco's integrated fuel and fleet management technology solutions are designed to address the multifaceted challenges of the mining industry.
  • In addition, the introduction of Gilbarco's clean fuel solution exemplifies the company's commitment to maintaining equipment integrity and performance.
  • Gilbarco's comprehensive site automation solutions empower mining companies with critical data analytic insights, facilitating efficient monitoring and management of fleet and fuel inventory.
  • Integral to the company's solutions is compliance with Global Industry Standards and environmental stewardship, from leak detection to vapour recovery and clean fuel technologies.

EQS-News: After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024

Retrieved on: 
Wednesday, March 13, 2024

After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024

Key Points: 
  • After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024
    The issuer is solely responsible for the content of this announcement.
  • Frank Niehage, CEO of flatexDEGIRO: "We can be justifiably proud of what we have achieved as a team at flatexDEGIRO over the past few months.
  • At the same time, flatexDEGIRO significantly reduced its marketing expenses by 30.4 percent to EUR 34.0 million in 2023 (2022: EUR 48.9 million).
  • From 2024, flatexDEGIRO will therefore dispense with adjustments in order to establish simpler and more transparent key figures.

Global Central Vacuum System Market Outlook, 2023-2024 and 2029: Key Opportunities Driven by Growth in Demand for CVS with Hepa Filters and Smart Vaccum Systems - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024

The global central vacuum systems market is highly competitive, with many vendors.

Key Points: 
  • The global central vacuum systems market is highly competitive, with many vendors.
  • Some of the major players dominating the global central vacuum systems market include Trovac, DrainVac, Nuera Air, Nilfisk Group, and Busch.
  • In Europe, the demand for central vacuum systems is experiencing an increase, driven by stringent hygiene standards in the food processing industry and concerns about air quality, and dominated the global central vacuum systems market share, accounting for over 38% in 2023.
  • Furthermore, the growth of central vacuum systems in the APAC is attributed to the APAC's expansion of manufacturing and metalworking facilities.

Yr ICO yn galw ar bobl i rannu profiadau wrth gael mynediad at gofnodion gofal, gan addo gwella’r cymorth

Retrieved on: 
Saturday, March 9, 2024

Mae Swyddfa'r Comisiynydd Gwybodaeth (ICO) yn galw ar bobl sydd â phrofiad o'r system ofal yn y Deyrnas Unedig i rannu'r heriau maen nhw wedi'u hwynebu wrth gael mynediad at eu cofnodion gofal gan sefydliadau.

Key Points: 


Mae Swyddfa'r Comisiynydd Gwybodaeth (ICO) yn galw ar bobl sydd â phrofiad o'r system ofal yn y Deyrnas Unedig i rannu'r heriau maen nhw wedi'u hwynebu wrth gael mynediad at eu cofnodion gofal gan sefydliadau.

Global Transaction Monitoring Market Outlook Report to 2028: A Forecasted $36.35 Billion Market by 2028, with CAGR of 16%

Retrieved on: 
Thursday, March 7, 2024

The Global Transaction Monitoring Market estimated at USD 17.25 Billion in 2023, is expected to reach USD 36.35 Billion by 2028 growing at a CAGR of 16.07%.

Key Points: 
  • The Global Transaction Monitoring Market estimated at USD 17.25 Billion in 2023, is expected to reach USD 36.35 Billion by 2028 growing at a CAGR of 16.07%.
  • Transaction monitoring is the management, inspection, and analysis of a completed transaction on a business application or information system.
  • The Global Transaction Monitoring Market is segmented based on Component, Deployment Mode, Organization Size, Function, Application, Industry, and Geography.
  • The BFSI sector is likely to account for a considerable portion of the global transaction monitoring market share.